A Review of Sleep Disturbance in Hepatitis C
Authors:
- Sanjeev SockalingamSSSanjeev Sockalingam
- Susan E. AbbeySASusan E. Abbey
- Fahad AlosaimiFAFahad Alosaimi
- Marta NovakMNMarta Novak
- 1 January 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 44 (1) , 38-45
Abstract
Sleep disturbances occur in up to 60% of patients with chronic hepatitis C (CHC) and is often interrelated with comorbid psychiatric disorders. Moreover, neuropsychiatric complications of interferon-alpha during CHC treatment can manifest as sleep problems. Newly diagnosed sleep disturbance occurs in up to 60% and 30% of untreated CHC patients and patients undergoing interferon-alpha therapy, respectively. However, the presentation of insomnia in patients with CHC is influenced by significant psychiatric comorbidity, such as depression, and medical conditions, such as anemia and hypothyroidism. Therefore, prompt recognition using screening tools and exclusion of comorbid conditions contributing sleep pathology can enhance treatment outcomes. Owing to the paucity of studies, treatment recommendations for sleep disorders in CHC patients are derived from recommendations from general sleep disorder treatment guidelines. Further research is needed to elucidate the efficacy of pharmacological and nonpharmacological treatments of sleep disorders in CHC patients.Keywords
This publication has 84 references indexed in Scilit:
- Fatigue and Health-Related Quality of Life (HRQL) in Chronic Hepatitis C Virus InfectionDigestive Diseases and Sciences, 2007
- Modafinil’s Use in Combating Interferon-Induced FatigueDigestive Diseases and Sciences, 2007
- Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapyClinical Practice & Epidemiology in Mental Health, 2007
- Symptom Prevalence and Clustering of Symptoms in People Living with Chronic Hepatitis C InfectionJournal of Pain and Symptom Management, 2006
- Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis CJournal of Hepatology, 2005
- IDO and interferon-α-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicityMolecular Psychiatry, 2004
- An Algorithm for the Management of Restless Legs SyndromeMayo Clinic Proceedings, 2004
- Psychopharmacological Treatment of Depression, Anxiety, Irritability and Insomnia in Patients Receiving Interferon-α: a Prospective Case Series and a Discussion of Biological MechanismsJournal of Psychopharmacology, 2004
- Rapid tryptophan depletion reverses phenelzine‐induced suppression of REM sleepJournal of Sleep Research, 2003
- Psychiatric symptoms related to interferon therapy for chronic hepatitis C: Clinical features and prognosisPsychiatry and Clinical Neurosciences, 2000